RepRegen CE marks tissue regeneration product
This article was originally published in Clinica
Executive Summary
RepRegen has CE marked StronBone, a biomaterial designed to repair and regenerate hard tissue, for sale in the EU. The product is a bioactive glass containing strontium, which boosts performance of bioceramics for bone repair, RepRegen says. The London, UK firm, formerly known as BioCeramic Therapeutics, said that the approval would allow it to accelerate discussions with potential strategic partners about its hard tissue product platform in general and StronBone in particular. RepRegen's other hard tissue repair products are geared towards the orthopaedic market, including some to address trauma and spinal defects, and craniomaxillofacial applications.
You may also be interested in...
Normality Reasserts Itself For Biotech IPOs
The highs of the COVID-19 era, and the lows that supplanted it, are beginning to fade.
MRM Health Pulls A Pouchitis Hit Out Of The Bag
The mid-stage success is encouraging, but taking on Takeda won’t be easy.
Novartis Draws Out Its APPLAUSE
Another data drop from Fabhalta’s IgAN trial looks encouraging, despite a missing abstract.